Combination therapy refers to the concurrent or sequential use of two or more treatments targeting the same pathophysiological axis, such as phosphodiesterase type-5 inhibitors (PDE5i) combined with low-intensity shockwave therapy (LIST) to enhance arterial supply to the corpora cavernosa
Notably, LOX oxidizes cell membranes via peroxyl (ROO) radicals and forms lipid hydroperoxides
*Compounded Tirzepatide available through Rixa Health's GLP-1 Prescription is produced in an FDA-registered facility but has not been evaluated by the FDA for safety, efficacy, or quality
Buckley ST, Bkdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-Rnne J, et al
Lifeist is committed to bringing natural products backed by real science to market and looks forward to reaching many more customers in 2024